With the analysis among 13,160 patents, we discovered top 439 key players by total patent application. Novartis AG, Amgen, Inc., Celgene Corp. are dominant in this area. They take 7.14% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 417
California, United States
Patent: 326
New Jersey, United States
Patent: 185
F. Hoffmann-La Roche Ltd.
Antwerpen, Belgium
Patent: 170
Indiana, United States
Patent: 155
Bayern, Germany
Patent: 129
Human Genome Sciences, Inc.
Washington, United States
Patent: 108
With the analysis among 324 patents, we discovered top 48 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, iOmx Therapeutics AG, Shenzhen Tajirui Biomedical Co. Ltd. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Bayern, Germany
Patent: 23
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 22
California, United States
Patent: 13
Deverra Therapeutics, Inc.
Washington, United States
Patent: 10
South Dakota, United States
Patent: 9
Massachusetts, United States
Patent: 9
Enliven Therapeutics, Inc. /US/
Colorado, United States
Patent: 6
With the analysis among related 5,150 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing MorphoSys AG, Amgen, Inc., Celgene Corp. take 4.16% of patent filing during this period.
Bayern, Germany
Patent: 81
California, United States
Patent: 70
New Jersey, United States
Patent: 63
Antwerpen, Belgium
Patent: 63
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 57
Institut National de la Santé et de la Recherche Médicale
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 54
Regents of The University of Michigan
Michigan, United States
Patent: 50
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 47
Tianjin Lakeside Pangu gene science development Company Limited
Tianjin Shi, China
Patent: 43
With the analysis among related 5,150 patents in last 5 years, we discover 206 new entrants. Iovance Biotherapeutics, Inc., Southern Research Institute, Magenta Therapeutics, Inc. are the most active new entrants in this area.
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 31
Southern Research Institute
Alabama, United States
Patent: 26
Magenta Therapeutics, Inc.
Massachusetts, United States
Patent: 25
California, United States
Patent: 25
Bayern, Germany
Patent: 23
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 22
Prelude Therapeutics, Inc.
Delaware, United States
Patent: 21
Bern, Switzerland
Patent: 20
Nottingham Trent University
NOTTINGHAM, United Kingdom
Patent: 19
With the analysis among 5,459 patents, we discovered top 278 universities and scientific research institutions by total patent application. China Pharmaceutical University, Zhejiang University, Texas A&M University are dominant in this area. They take 8.17% of the total patent filing.
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 64
Zhejiang Sheng, China
Patent: 63
Texas, United States
Patent: 55
Guangdong Sheng, China
Patent: 53
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 53
Shanghai Shi, China
Patent: 49
The Johns Hopkins University
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 36
Illinois, United States
Patent: 36
Tennessee, United States
Patent: 32